Health Care: Drugs

Immunomedics Inc (IMMU: NASDAQ)

$3.34 -0.1 | -2.91%
07/25/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.44
52 Week High 7.35
52 Week Low 3.04
Avg. Daily Vol. (Mil) 0.77
Beta (3 year) 0.64
Share Related Items
Mkt Cap (Mil) 318.12
Shares Out (Mil) 92.48
Float (Mil) 65.74
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.60
Current Ratio 5.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 34.52
Price/Book 15.51
Price/Cash Flow -9.90
Per Share Data
Earnings -0.37
Sales 0.10
Book Value 0.22
Cash Flow -0.35
Business Summary
Immunomedics, Inc., is a biopharmaceutical company which is focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
General Information
300 American Road
Morris Plains, NJ 07950
Industry : Drugs
Sector: Health Care
Employees: 119
CEO: Ms. Cynthia L. Sullivan
Short Interest
Current Month (Mil) 12.25
Previous Month (Mil) 12.47
Short Interest Ratio (Days) 23.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -114.90
Return on Investments -147.00
Gross Margin 63.00
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with IMMU

Latest IMMU Headlines from TheStreet

More Financial News for IMMU

Press Releases for IMMU

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter